0001209191-15-065926.txt : 20150813
0001209191-15-065926.hdr.sgml : 20150813
20150813202050
ACCESSION NUMBER: 0001209191-15-065926
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150811
FILED AS OF DATE: 20150813
DATE AS OF CHANGE: 20150813
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitchell David Chilton
CENTRAL INDEX KEY: 0001627684
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 151052251
MAIL ADDRESS:
STREET 1: C/O AQUINOX PHARMACEUTICALS, INC.
STREET 2: 450 - 887 GREAT NORTHERN WAY
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-11
0
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0001627684
Mitchell David Chilton
C/O AQUINOX PHARMACEUTICALS, INC.
450 - 887 GREAT NORTHERN WAY
VANCOUVER
A1
V5T 4T5
BRITISH COLUMBIA, CANADA
0
1
0
0
VP Global Regulatory & Quality
Common Stock
2015-08-11
4
P
0
1600
24.36
A
1600
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.255 to $24.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote.
/s/ David C. Mitchell
2015-08-13